Explore the words cloud of the Aseptic Smart project. It provides you a very rough idea of what is the project "Aseptic Smart" about.
The following table provides information about the project.
PHARMA INTEGRATION SRL
|Coordinator Country||Italy [IT]|
|Total cost||3˙694˙625 €|
|EC max contribution||2˙586˙237 € (70%)|
1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
|Duration (year-month-day)||from 2019-06-01 to 2021-05-31|
Take a look of project's partnership.
|1||PHARMA INTEGRATION SRL||IT (SIENA)||coordinator||938˙175.00|
|2||SKAN AG||CH (ALLSCHWIL)||participant||761˙687.00|
|3||CILAG AG||CH (SCHAFFHAUSEN)||participant||441˙000.00|
|4||IPREL PROGETTI SRL||IT (IMOLA (BO))||participant||296˙625.00|
|5||VISION EQUIPMENT DOO BEOGRAD-SAVSKIVENAC||RS (BELGRADE)||participant||148˙750.00|
'Aseptic Smart will demonstrate a novel fully robotised, multifunctional pharmaceutical filling line with capabilities of processing several container types (vials, syringes, cartridges, ampoules, etc.) and thus bringing the sector to the fore of Industry 4.0 revolution, which is the future of manufacturing in Europe. The technology enables fast changeovers ( 30 minutes) thus providing manufacturing flexibility and agility critical in processing smaller batches of more personalised injectable medicines. Robots eliminate the need for human intervention in aseptic area and thus solve two traditional challenges within the pharma industry-sterility assurance and contamination risk reduction. Machines have a modular design which allows cheaper and faster scaling out through addition of more modules where production increase is required and reduces technology transfer costs by 94%. The technology has the following additional advantages#58;58% lower operational costs - ca. 87% less parts reduce maintenance costs and energy consumption;Compact – up to 50% smaller size as robots replace bulky material movement components e.g. conveyor belts delivering manufacturing space savings;Increased process repeatability – robots reduce rejection rates to virtually zero (less than 0.05%)Because of this, the technology has attracted interest of some large pharma companies who, like several others, are shifting from developing quot;blockbusterquot; drugs towards personalised medicine; driving growth of the €6.6 billion global pharma packaging equipment market. The project will refine robot gripping system, integrate machines to robots, develop machine vision and control system before validation and end user demonstration in actual environment. This will support fast commercialisation enabling the consortium to capture 1.5% of the market 5 years after commercialisation, translating to cumulative consortium revenue of over earn cumulative revenues of €97m and return on investment of 696%.'
|Aseptic Smart project website||Websites, patent fillings, videos etc.||2020-02-27 15:23:51|
Take a look to the deliverables list in detail: detailed list of Aseptic Smart deliverables.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ASEPTIC SMART" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (firstname.lastname@example.org) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "ASEPTIC SMART" are provided by the European Opendata Portal: CORDIS opendata.